▶ 調査レポート

世界のメタボロミクスバイオマーカー市場:市場規模・現状・予測

• 英文タイトル:Global Metabolomics Biomarker Market Size, Status and Forecast 2019-2025

QYResearchが調査・発行した産業分析レポートです。世界のメタボロミクスバイオマーカー市場:市場規模・現状・予測 / Global Metabolomics Biomarker Market Size, Status and Forecast 2019-2025 / QYR9N7546資料のイメージです。• レポートコード:QYR9N7546
• 出版社/出版日:QYResearch / 2019年6月14日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、96ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医療・製薬・バイオ
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当資料は、メタボロミクスバイオマーカーのグローバル市場について調査・分析したレポートで、種類別(ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、その他)、用途別(毒物学、薬物検査、がん、心血管障害、神経学的障害、その他)、主要地域別(アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米)の市場規模、市場予測、関連企業情報などが含まれています。

・メタボロミクスバイオマーカーの世界市場規模
・主要企業別市場シェア
・メタボロミクスバイオマーカーの世界市場規模:種類別(ガスクロマトグラフィー、高速液体クロマトグラフィー、超高速液体クロマトグラフィー、核磁気共鳴、質量分析、その他)
・メタボロミクスバイオマーカーの世界市場規模:用途別(毒物学、薬物検査、がん、心血管障害、神経学的障害、その他)
・メタボロミクスバイオマーカーのアメリカ市場規模(種類別、用途別)
・メタボロミクスバイオマーカーのヨーロッパ市場規模(種類別、用途別)
・メタボロミクスバイオマーカーの中国市場規模(種類別、用途別)
・メタボロミクスバイオマーカーの日本市場規模(種類別、用途別)
・メタボロミクスバイオマーカーの東南アジア市場規模(種類別、用途別)
・メタボロミクスバイオマーカーのインド市場規模(種類別、用途別)
・メタボロミクスバイオマーカーの中南米市場規模(種類別、用途別)
・主要企業別分析(企業概要、製品動向、販売量など)
・メタボロミクスバイオマーカーの世界市場予測(2019年-2025年)
・メタボロミクスバイオマーカーの地域別市場予測(2019年-2025年)
...

Metabolomics is referred as the large-scale study of small molecules, commonly known as metabolites, within tissues, cells, biofluids or organisms.Innovative development in informatics and analytical technologies and increasing pharmaceutical and biotech R&D expenditure are expected to significantly contribute in the market growth during forecast period. Other factors such as ongoing research on metabolomics biomarker and extensive application of metabolomics biomarker such as in colorectal cancer detection are also expected to drive the market growth. Further, increasing pharmaceutical and biotech R&D expenditure is also contributing in the market.
In 2018, the global Metabolomics Biomarker market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Metabolomics Biomarker status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolomics Biomarker development in United States, Europe and China.

The key players covered in this study
Biocrates Life Sciences
Biomark Diagnostics
Chenomx
Creative Proteomics
Evotec
Human Metabolome Technologies
Merck
Metabolomic Diagnostics
Metabolon
Ovid Therapeutics

Market segment by Type, the product can be split into
Gas chromatography
High-performance liquid chromatography
Ultra-performance liquid chromatography
Nuclear magnetic resonance
Mass spectrometry
Surface-based mass analysis
Bioinformatics

Market segment by Application, split into
Toxicological studies
Drug testing
Cancer
Cardiovascular disorders
Neurological disorders
Inborn errors of metabolism

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Metabolomics Biomarker status, future forecast, growth opportunity, key market and key players.
To present the Metabolomics Biomarker development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Metabolomics Biomarker are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Metabolomics Biomarker Market Size Growth Rate by Type (2014-2025)
1.4.2 Gas chromatography
1.4.3 High-performance liquid chromatography
1.4.4 Ultra-performance liquid chromatography
1.4.5 Nuclear magnetic resonance
1.4.6 Mass spectrometry
1.4.7 Surface-based mass analysis
1.4.8 Bioinformatics
1.5 Market by Application
1.5.1 Global Metabolomics Biomarker Market Share by Application (2014-2025)
1.5.2 Toxicological studies
1.5.3 Drug testing
1.5.4 Cancer
1.5.5 Cardiovascular disorders
1.5.6 Neurological disorders
1.5.7 Inborn errors of metabolism
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Metabolomics Biomarker Market Size
2.2 Metabolomics Biomarker Growth Trends by Regions
2.2.1 Metabolomics Biomarker Market Size by Regions (2014-2025)
2.2.2 Metabolomics Biomarker Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Metabolomics Biomarker Market Size by Manufacturers
3.1.1 Global Metabolomics Biomarker Revenue by Manufacturers (2014-2019)
3.1.2 Global Metabolomics Biomarker Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Metabolomics Biomarker Market Concentration Ratio (CR5 and HHI)
3.2 Metabolomics Biomarker Key Players Head office and Area Served
3.3 Key Players Metabolomics Biomarker Product/Solution/Service
3.4 Date of Enter into Metabolomics Biomarker Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Metabolomics Biomarker Market Size by Type (2014-2019)
4.2 Global Metabolomics Biomarker Market Size by Application (2014-2019)

5 United States
5.1 United States Metabolomics Biomarker Market Size (2014-2019)
5.2 Metabolomics Biomarker Key Players in United States
5.3 United States Metabolomics Biomarker Market Size by Type
5.4 United States Metabolomics Biomarker Market Size by Application

6 Europe
6.1 Europe Metabolomics Biomarker Market Size (2014-2019)
6.2 Metabolomics Biomarker Key Players in Europe
6.3 Europe Metabolomics Biomarker Market Size by Type
6.4 Europe Metabolomics Biomarker Market Size by Application

7 China
7.1 China Metabolomics Biomarker Market Size (2014-2019)
7.2 Metabolomics Biomarker Key Players in China
7.3 China Metabolomics Biomarker Market Size by Type
7.4 China Metabolomics Biomarker Market Size by Application

8 Japan
8.1 Japan Metabolomics Biomarker Market Size (2014-2019)
8.2 Metabolomics Biomarker Key Players in Japan
8.3 Japan Metabolomics Biomarker Market Size by Type
8.4 Japan Metabolomics Biomarker Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Metabolomics Biomarker Market Size (2014-2019)
9.2 Metabolomics Biomarker Key Players in Southeast Asia
9.3 Southeast Asia Metabolomics Biomarker Market Size by Type
9.4 Southeast Asia Metabolomics Biomarker Market Size by Application

10 India
10.1 India Metabolomics Biomarker Market Size (2014-2019)
10.2 Metabolomics Biomarker Key Players in India
10.3 India Metabolomics Biomarker Market Size by Type
10.4 India Metabolomics Biomarker Market Size by Application

11 Central & South America
11.1 Central & South America Metabolomics Biomarker Market Size (2014-2019)
11.2 Metabolomics Biomarker Key Players in Central & South America
11.3 Central & South America Metabolomics Biomarker Market Size by Type
11.4 Central & South America Metabolomics Biomarker Market Size by Application

12 International Players Profiles
12.1 Biocrates Life Sciences
12.1.1 Biocrates Life Sciences Company Details
12.1.2 Company Description and Business Overview
12.1.3 Metabolomics Biomarker Introduction
12.1.4 Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2014-2019)
12.1.5 Biocrates Life Sciences Recent Development
12.2 Biomark Diagnostics
12.2.1 Biomark Diagnostics Company Details
12.2.2 Company Description and Business Overview
12.2.3 Metabolomics Biomarker Introduction
12.2.4 Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2014-2019)
12.2.5 Biomark Diagnostics Recent Development
12.3 Chenomx
12.3.1 Chenomx Company Details
12.3.2 Company Description and Business Overview
12.3.3 Metabolomics Biomarker Introduction
12.3.4 Chenomx Revenue in Metabolomics Biomarker Business (2014-2019)
12.3.5 Chenomx Recent Development
12.4 Creative Proteomics
12.4.1 Creative Proteomics Company Details
12.4.2 Company Description and Business Overview
12.4.3 Metabolomics Biomarker Introduction
12.4.4 Creative Proteomics Revenue in Metabolomics Biomarker Business (2014-2019)
12.4.5 Creative Proteomics Recent Development
12.5 Evotec
12.5.1 Evotec Company Details
12.5.2 Company Description and Business Overview
12.5.3 Metabolomics Biomarker Introduction
12.5.4 Evotec Revenue in Metabolomics Biomarker Business (2014-2019)
12.5.5 Evotec Recent Development
12.6 Human Metabolome Technologies
12.6.1 Human Metabolome Technologies Company Details
12.6.2 Company Description and Business Overview
12.6.3 Metabolomics Biomarker Introduction
12.6.4 Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2014-2019)
12.6.5 Human Metabolome Technologies Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Metabolomics Biomarker Introduction
12.7.4 Merck Revenue in Metabolomics Biomarker Business (2014-2019)
12.7.5 Merck Recent Development
12.8 Metabolomic Diagnostics
12.8.1 Metabolomic Diagnostics Company Details
12.8.2 Company Description and Business Overview
12.8.3 Metabolomics Biomarker Introduction
12.8.4 Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2014-2019)
12.8.5 Metabolomic Diagnostics Recent Development
12.9 Metabolon
12.9.1 Metabolon Company Details
12.9.2 Company Description and Business Overview
12.9.3 Metabolomics Biomarker Introduction
12.9.4 Metabolon Revenue in Metabolomics Biomarker Business (2014-2019)
12.9.5 Metabolon Recent Development
12.10 Ovid Therapeutics
12.10.1 Ovid Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Metabolomics Biomarker Introduction
12.10.4 Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2014-2019)
12.10.5 Ovid Therapeutics Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Metabolomics Biomarker Key Market Segments
Table Key Players Metabolomics Biomarker Covered
Table Global Metabolomics Biomarker Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Metabolomics Biomarker Market Size Market Share by Type 2014-2025
Figure Gas chromatography Figures
Table Key Players of Gas chromatography
Figure High-performance liquid chromatography Figures
Table Key Players of High-performance liquid chromatography
Figure Ultra-performance liquid chromatography Figures
Table Key Players of Ultra-performance liquid chromatography
Figure Nuclear magnetic resonance Figures
Table Key Players of Nuclear magnetic resonance
Figure Mass spectrometry Figures
Table Key Players of Mass spectrometry
Figure Surface-based mass analysis Figures
Table Key Players of Surface-based mass analysis
Figure Bioinformatics Figures
Table Key Players of Bioinformatics
Table Global Metabolomics Biomarker Market Size Growth by Application 2014-2025 (Million US$)
Figure Toxicological studies Case Studies
Figure Drug testing Case Studies
Figure Cancer Case Studies
Figure Cardiovascular disorders Case Studies
Figure Neurological disorders Case Studies
Figure Inborn errors of metabolism Case Studies
Figure Metabolomics Biomarker Report Years Considered
Table Global Metabolomics Biomarker Market Size 2014-2025 (Million US$)
Figure Global Metabolomics Biomarker Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Metabolomics Biomarker Market Size by Regions 2014-2025 (Million US$)
Table Global Metabolomics Biomarker Market Size by Regions 2014-2019 (Million US$)
Table Global Metabolomics Biomarker Market Share by Regions 2014-2019
Figure Global Metabolomics Biomarker Market Share by Regions 2014-2019
Figure Global Metabolomics Biomarker Market Share by Regions 2019
Table Market Top Trends
Table Global Metabolomics Biomarker Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Metabolomics Biomarker Market Share by Manufacturers (2014-2019)
Figure Global Metabolomics Biomarker Market Share by Manufacturers in 2018
Table Global Metabolomics Biomarker Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Metabolomics Biomarker Product/Solution/Service
Table Date of Enter into Metabolomics Biomarker Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table Global Metabolomics Biomarker Market Size Share by Type (2014-2019)
Figure Global Metabolomics Biomarker Market Size Market Share by Type (2014-2019)
Table Global Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table Global Metabolomics Biomarker Market Size Share by Application (2014-2019)
Figure Global Metabolomics Biomarker Market Size Market Share by Application (2014-2019)
Figure Global Metabolomics Biomarker Revenue Market Share by Application in 2018
Figure United States Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table United States Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table United States Key Players Metabolomics Biomarker Market Share (2018-2019)
Table United States Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table United States Metabolomics Biomarker Market Share by Type (2014-2019)
Table United States Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table United States Metabolomics Biomarker Market Share by Application (2014-2019)
Figure Europe Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table Europe Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table Europe Key Players Metabolomics Biomarker Market Share (2018-2019)
Table Europe Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table Europe Metabolomics Biomarker Market Share by Type (2014-2019)
Table Europe Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table Europe Metabolomics Biomarker Market Share by Application (2014-2019)
Figure China Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table China Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table China Key Players Metabolomics Biomarker Market Share (2018-2019)
Table China Metabolomics Biomarker Market Size by Type (2014-20189) (Million US$)
Table China Metabolomics Biomarker Market Share by Type (2014-2019)
Table China Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table China Metabolomics Biomarker Market Share by Application (2014-2019)
Figure Japan Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table Japan Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table Japan Key Players Metabolomics Biomarker Market Share (2018-2019)
Table Japan Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table Japan Metabolomics Biomarker Market Share by Type (2014-2019)
Table Japan Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table Japan Metabolomics Biomarker Market Share by Application (2014-2019)
Figure Southeast Asia Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Metabolomics Biomarker Market Share (2018-2019)
Table Southeast Asia Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Metabolomics Biomarker Market Share by Type (2014-2019)
Table Southeast Asia Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Metabolomics Biomarker Market Share by Application (2014-2019)
Figure India Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table India Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table India Key Players Metabolomics Biomarker Market Share (2018-2019)
Table India Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table India Metabolomics Biomarker Market Share by Type (2014-2019)
Table India Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table India Metabolomics Biomarker Market Share by Application (2014-2019)
Figure Central & South America Metabolomics Biomarker Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Metabolomics Biomarker Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Metabolomics Biomarker Market Share (2018-2019)
Table Central & South America Metabolomics Biomarker Market Size by Type (2014-2019) (Million US$)
Table Central & South America Metabolomics Biomarker Market Share by Type (2014-2019)
Table Central & South America Metabolomics Biomarker Market Size by Application (2014-2019) (Million US$)
Table Central & South America Metabolomics Biomarker Market Share by Application (2014-2019)
Table Biocrates Life Sciences Company Details
Table Biocrates Life Sciences Revenue in Metabolomics Biomarker Business (2014-2019) (Million US$)
Figure Biocrates Life Sciences Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Biocrates Life Sciences Recent Development
Table Biomark Diagnostics Company Details
Table Biomark Diagnostics Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Biomark Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Biomark Diagnostics Recent Development
Table Chenomx Company Details
Table Chenomx Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Chenomx Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Chenomx Recent Development
Table Creative Proteomics Company Details
Table Creative Proteomics Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Creative Proteomics Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Creative Proteomics Recent Development
Table Evotec Company Details
Table Evotec Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Evotec Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Evotec Recent Development
Table Human Metabolome Technologies Company Details
Table Human Metabolome Technologies Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Human Metabolome Technologies Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Human Metabolome Technologies Recent Development
Table Merck Company Details
Table Merck Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Merck Recent Development
Table Metabolomic Diagnostics Company Details
Table Metabolomic Diagnostics Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Metabolomic Diagnostics Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Metabolomic Diagnostics Recent Development
Table Metabolon Company Details
Table Metabolon Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Metabolon Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Metabolon Recent Development
Table Ovid Therapeutics Company Details
Table Ovid Therapeutics Revenue in Metabolomics Biomarker Business (2014-2019)(Million US$)
Figure Ovid Therapeutics Revenue Growth Rate in Metabolomics Biomarker Business (2014-2019)
Table Ovid Therapeutics Recent Development
Table Global Metabolomics Biomarker Market Size by Regions (Million US$) 2019-2025
Figure Global Metabolomics Biomarker Market Size Share by Regions (2019-2025)
Figure Global Metabolomics Biomarker Market Size Share by Regions in 2025
Figure United States Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Europe Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure China Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Japan Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure India Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Metabolomics Biomarker Market Size Forecast (2019-2025)(Million USD)
Table Global Metabolomics Biomarker Market Size by Product (2019-2025) (Million US$)
Figure Global Metabolomics Biomarker Market Size by Product (2019-2025)
Figure Global Metabolomics Biomarker Market Size by Product in 2025
Table Global Metabolomics Biomarker Market Size by Application (2019-2025) (Million US$)
Figure Global Metabolomics Biomarker Market Size by Application (2019-2025)
Figure Global Metabolomics Biomarker Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources